| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.16B | 41.21B | 39.42B | 39.37B | 40.01B | 37.54B |
| Gross Profit | 10.99B | 11.28B | 10.14B | 9.82B | 8.71B | 7.45B |
| EBITDA | 5.29B | 6.31B | 5.28B | 5.31B | 4.55B | 2.51B |
| Net Income | 2.52B | 3.23B | 2.56B | 2.73B | 2.40B | 882.00M |
Balance Sheet | ||||||
| Total Assets | 47.25B | 51.31B | 48.41B | 47.84B | 46.40B | 43.94B |
| Cash, Cash Equivalents and Short-Term Investments | 16.50B | 18.67B | 17.17B | 17.22B | 17.55B | 15.95B |
| Total Debt | 1.37B | 1.41B | 1.29B | 1.52B | 1.68B | 1.37B |
| Total Liabilities | 9.20B | 9.73B | 9.55B | 10.03B | 10.41B | 10.66B |
| Stockholders Equity | 38.04B | 41.57B | 38.87B | 37.81B | 35.99B | 33.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.81B | 3.07B | 1.66B | 2.24B | 256.00M |
| Operating Cash Flow | 0.00 | 5.23B | 4.72B | 3.52B | 3.76B | 1.15B |
| Investing Cash Flow | 0.00 | -3.14B | -1.63B | -3.02B | -684.00M | 1.48B |
| Financing Cash Flow | 0.00 | -3.40B | -3.65B | -3.35B | -1.48B | -1.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥32.09B | 12.36 | ― | 5.22% | -4.88% | -8.72% | |
73 Outperform | ¥31.06B | 11.64 | ― | 4.44% | 5.20% | -3.07% | |
73 Outperform | ¥54.13B | 15.29 | ― | 1.10% | 9.96% | 3.13% | |
68 Neutral | ¥48.18B | 58.83 | ― | 2.38% | 4.30% | -66.03% | |
67 Neutral | $45.14B | 24.84 | 2.45% | 2.44% | 5.79% | 193.93% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |